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SUMMARY
The E3 ubiquitin ligase Mule is often overexpressed in human colorectal cancers, but its role in 
gut tumorigenesis is unknown. Here, we show in vivo that Mule controls murine intestinal stem 
and progenitor cell proliferation by modulating Wnt signaling via c-Myc. Mule also regulates 
protein levels of the receptor tyrosine kinase EphB3 by targeting it for proteasomal and lysosomal 
degradation. In the intestine, EphB/ephrinB interactions position cells along the crypt-villus axis 
and compartmentalize incipient colorectal tumors. Our study thus unveils an important new avenue 
by which Mule acts as an intestinal tumor suppressor by regulation of the intestinal stem cell 
niche.
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Graphical Abstract
INTRODUCTION
Human colorectal carcinogenesis follows a defined sequence of histopathological changes 
associated with specific genetic alterations (Fearon and Vogelstein, 1990). These alterations 
most often affect Wnt signaling pathway components, notably the adenomatous polyposis 
coli (APC) gene (Groden et al., 1991; Nagase and Nakamura, 1993). Loss of APC function 
drives aberrant Wnt activation, resulting in β-catenin translocation from cytoplasm to 
nucleus and constitutive activation of β-catenin/ TCF target genes (Clevers, 2006). Two such 
targets relevant to our study are c-Myc and EphB3.
c-Myc is overexpressed in 70% of human colorectal cancers (Augenlicht et al., 1997). 
Transcription regulated by c-Myc is context dependent and drives responses ranging from 
increased proliferation to apoptosis (Dang et al., 2006). The abnormalities in intestinal cell 
proliferation, migration, differentiation, and apoptosis resulting from APC inactivation 
depend entirely on c-Myc (Sansom et al., 2007).
The EphB receptor tyrosine kinases are direct Wnt/β-catenin targets involved in patterning 
the intestinal crypt-villus axis (Batlle et al., 2002). Once engaged by membrane-bound 
ephrins, EphB receptors (EphB) mediate bi-directional signaling that dictates intestinal cell 
positioning (Himanen et al., 2001). In normal intestine, a gradient of EphB expression 
prevails, with the highest EphB levels at the crypt base. Conversely, an inverse gradient of 
ephrin expression exists, with the highest levels of these ligands at the villus tip (Batlle et al., 
2002). EphB3-deficient (EphB3−/−) mice show mispositioned Paneth cells that are no longer 
concentrated in the crypts but instead scattered along the crypt-villus axis (Batlle et al., 
2002).
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The E3 ubiquitin ligase Mule, also known as Huwe1 and Arf-BP1, mainly targets substrates 
for degradation by attaching lysine 48 (K48)-linked polyubiquitin (pUb) chains. However, 
Mule-mediated K63-linked ubiquitination (Ubn) of c-Myc promotes its transcriptional 
activity (Adhikary et al., 2005), and that of the Wnt pathway component Disheveled (Dvl) 
inhibits the Dvl multimerization necessary for Wnt signaling (de Groot et al., 2014). The 
total-Mule-knockout mouse is embryonic lethal (Hao et al., 2012; Kon et al., 2012), and 
studies of conditional Mule mutants conflict on whether Mule is an oncogene or a tumor 
suppressor (Hao et al., 2012; Inoue et al., 2013; Kon et al., 2012; Zhao et al., 2008). In situ 
hybridization of colon tumor microarrays showed that Mule increased with tumor grade, 
suggesting that Mule is an oncogene (Adhikary et al., 2005). However, our previous study of 
Mule deficiency in a mouse model of 7,12-dimethylbenz[a]-anthracene (DMBA)/12-O-
tetradecanoylphorbol-13-acetate (PMA)-induced skin cancer demonstrated that Mule is a 
tumor suppressor in skin (Inoue et al., 2013). Here, we show that Mule regulates intestinal 
cell sorting via EphB3 Ubn and also suppresses tumors by regulating c-Myc so as to fine-
tune the Wnt pathway and dampen the proliferation of stem and progenitor cells.
RESULTS
Loss of Mule Exacerbates the APCmin Phenotype
To clarify Mule’s role in colon cancer, we crossed Mulefl/fl(y) (Mule cKO) mice (Hao et al., 
2012) to Villin-Cre mice (Madison et al., 2002), in which Cre-mediated gene deletion occurs 
in intestinal epithelia starting at embryonic day 12.5 (Madison et al., 2002). We then crossed 
Mule cKO;Villin-Cre mice to APCmin mice, a mouse model of colon cancer (Su et al., 
1992), to generate Mule cKO;Villin-Cre;APCmin mice (designated Mule cKO APCmin). We 
followed cohorts of control APCmin mice (n = 20) and Mule cKO APCmin mice (n = 33) and 
sacrificed them at predetermined humane endpoints. While APCmin mice lived for 4–9 
months (mean 5 months), all Mule cKO APCmin mice had died by age 2–6 months (mean 4 
months) (Figure 1A). Control Villin-Cre APCmin mice died with kinetics similar to APCmin 
mice, confirming that the Villin-Cre construct is not driving disease in Mule cKO APCmin 
mice. Mule cKO APCmin mice exhibited a ~9-fold increase in total adenoma numbers in 
small intestine and colon compared to age-matched APCmin littermates (Figures 1B–1E), 
with a 4-fold difference apparent when mice of all ages were compared (Figures S1A and 
S1B). Villin-Cre APCmin and APCmin mice had comparable numbers of adenomas (Figures 
S1A and S1B). Most adenomas were low-grade dysplasias, although some were high-grade 
dysplasias or intramucosal carcinomas (Figures S1C and S1D). Our finding that Mule 
deficiency accelerates adenoma development in APCmin mice indicates that Mule is a tumor 
suppressor in the gut.
Mule-Deficient APCmin Mice Exhibit Hyperactivated Wnt/β-Catenin Signaling and Develop 
Adenomas Populated by Intestinal Stem Cells and Paneth Cells
Because Wnt is the main driver of intestinal cell proliferation, we compared nuclear β-
catenin levels in adenomas of APCmin and Mule cKO APCmin mice. Nuclear β-catenin was 
observed in adenomas in both strains (Figures 2A–2D). Mule cKO APCmin adenomas 
contained more Ki67+ proliferating cells than APCmin adenomas (Figures S1E–S1H) but 
showed no difference in apoptosis (Figures S1I–S1L). Most Mule cKO APCmin adenomas 
Dominguez-Brauer et al. Page 3
Cell Stem Cell. Author manuscript; available in PMC 2016 December 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
also contained more c-Myc+ cells than APCmin adenomas (Figures 2E–2H). 
Immunohistochemistry (IHC) to detect L-fatty acid binding protein (LFABP; a marker for 
enterocytes), periodic acid Schiff (PAS; goblet cells), chromogranin A (neuroendocrine 
cells), lysozyme or cryptidin (Paneth cells), and Olmf4 or Lgr5 (intestinal stem cells [ISCs]) 
revealed that Mule cKO APCmin adenomas were more heavily populated with ISCs (Figures 
2I–2L, S1W, and S1X) and Paneth cells (Figures 2M–2P, S1S, and S1T) than APCmin 
adenomas. Thus, loss of Mule in the APCmin background promotes an increase in c-Myc 
that enhances cellular proliferation and increases numbers of adenomas populated by greater 
numbers of ISC and Paneth cells.
Loss of Mule Alone Is Sufficient to Promote Tumorigenesis
To isolate the contribution of Mule deficiency to the tumorigenesis observed in Mule cKO 
APCmin mice, we studied our Mulefl/fl(y) Villin-Cre (Mule cKO) mice in more detail. To 
determine Mule’s normal localization in the gut, we performed in situ hybridization of 
intestinal tissue from Lgr5-EGFP-CreERT2+ (Barker et al., 2007) Apcfl/fl mice and 
demonstrated that Mule is found within the ISC niche (Figure S2A). This result was 
confirmed by IHC for GFP, to mark Lgr5+ stem cells (Figure S2B), and lysozyme staining to 
mark Paneth cells (Figure S2C). Additionally, RNAscope in situ hybridization which 
employs specific RNA probes to detect mRNA expression of a gene of interest at the single 
cell level, showed that in WT tissue ~5-fold more crypt cells coexpress both Mule and Lgr5 
mRNA puncta (Figures S2D and S2E) than Mule mRNA alone. Immunoblotting of isolated 
villus and crypt fractions from three pairs of Mule cKO (normal APC) and Mulefl/fl(y) wild-
type (WT) littermates confirmed the presence of Mule in intestinal crypts (Figure S2F). 
However, although Mule cKO mutants appeared to develop normally, they showed an 
increase in the number of BrdU+ cells per crypt in small intestine and colon at 4 months of 
age compared to WT controls (Figures S2G and S2H). Consequently, Mule cKO intestine 
exhibited enlarged crypts and elongated villi (Figures 3A and 3B). No defects were detected 
in cell migration along the crypt-villus axis (Figure S2I), in cell death (Figures S2J–S2L), or 
in the differentiation of five major intestinal cell types, but Paneth cells were strikingly 
mislocalized in Mule cKO intestine (Figure 3A–D.
To determine if Mule cKO mice spontaneously developed adenomas, a cohort was aged for 2 
years, by which time 50% had indeed developed abnormal growths (Figure S3A–S3D). 
Intriguingly, unlike Mule cKO APCmin adenomas, ~20% of the lesions in Mule cKO mice 
progressed to cancers. When we stained Mule cKO adenomas to detect β-catenin and 
histological markers, we observed abundant β-catenin in adenoma cell nuclei (Figures 3E–
3G and S3E–S3P), suggesting that Mule’s absence hyperactivates Wnt signaling. Indeed, in 
Mule cKO crypt cells, the Wnt targets Axin-2, MMP7, Tiam1, Sox9, and CD44 were all 
upregulated compared to WT controls (Figure S3Q). RNAscope in situ hybridization 
revealed that Mule co-localizes with Lgr5+ stem cells in APCmin adenomas and accounts for 
~45% of the cells within an adenoma (Figures S3R–S3U). Thus, Mule is expressed in cancer 
stem cells (CSCs) and may itself be amplified by Wnt signaling.
c-Myc is both a Mule substrate and a downstream Wnt target, so that APC inactivation that 
hyperactivates Wnt signaling increases c-Myc expression (Sansom et al., 2007). To assess 
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the contribution of Mule deficiency to the increased c-Myc+ cells in Mule cKO APCmin 
intestine, we examined the guts of adult Mule cKO mice. The enlarged crypts of Mule-
deficient intestines housed ~2-fold more c-Myc+ cells than WT crypts (Figures S4A–S4C). 
β-Catenin remained cytoplasmic in Mule cKO cells (Figures S4D and S4E). Adenomas in 
aged Mule cKO mice contained ~65% c-Myc+ cells (Figures 3H–3J and S4F) and were 
largely populated by Lgr5+Olmf4+ ISCs (Figures 3K–3M, S3O, and S3P) and 
cryptidin-4+lysozyme+ Paneth cells (Figures 3N–3P, S3K, and S3L).
Next, we generated intestinal organoids (Sato et al., 2011) as a model system to study stem 
cell-driven proliferation and gene expression in our Mule cKO versus WT mice in vitro. We 
found that Mule cKO organoids initially grew with faster kinetics than WT organoids, which 
was of interest since proliferation in organoids is driven by c-Myc expression in Lgr5+ stem 
cells. Mule cKO organoids, however, showed a growth deficit by day 44 (Figures S4G–
S4O). The mutant organoids were highly disorganized and Paneth cells were mislocalized. 
By day 66, the Mule cKO organoids had become undifferentiated spherical cysts (Figures 
S4M–S4O), a morphology that correlates with elevated Wnt signaling and is observed in 
APC-deficient organoids (Fatehullah et al., 2013). RT-PCR examination of RNA from Mule 
cKO and WT organoids confirmed that the Wnt targets c-Myc, Axin-2, Sox9, CD44, and 
Ascl2 were all upregulated in mutant organoids, and that the stem cell markers Lgr5 and 
Olmf4 were increased 3-and 5-fold, respectively (Figure S4P). Thus, Mule regulates c-Myc 
in intestinal cells to dampen proliferation and promote differentiation, and thereby opposes 
ISC expansion.
Loss of c-Myc in Mule cKO Mice Restores Normal Cell Proliferation but Does Not Rescue 
Paneth Cell Mispositioning
c-Myc deficiency rescues phenotypes of APC ablation (Sansom et al., 2004, 2007); we 
therefore tested if loss of c-Myc could also mitigate the abnormalities of Mule cKO mice. 
Mule cKO mice were crossed with c-Mycfl/flVillin-Cre (c-Myc cKO) mice to generate Mule 
c-Myc cDKO mutants. Since Villin-Cre-mediated deletion of c-Myc is never complete and 
some c-Myc+ cells escape to repopulate the crypts (Muncan et al., 2006), we immunostained 
Mule cKO and Mule c-Myc cDKO intestines to compare c-Myc levels. At 4 months, crypts 
in double mutant intestines actually contained more c-Myc+ cells than in single mutant 
crypts (Figures S5A and S5B), possibly due to the increased Wnt pathway activity that 
occurs in the absence of Mule. The aberrant morphology of c-Myc-deficient crypts was 
consistent with c-Myc’s role in crypt formation (Bettess et al., 2005). Mule cKO intestine 
displayed ~15 more BrdU+ cells/crypt than WT controls (Figures 4A, 4B, and 4E), while c-
Myc KO and Mule c-Myc cDKO crypts, despite their repopulation by c-Myc+ cells, both 
contained ~10 BrdU+ cells/crypt (Figures 4C–4E, S5C, and S5D). c-Myc cKO and Mule c-
Myc cDKO crypt cells were also smaller than WT and Mule cKO crypt cells. These results 
are in line with published data showing that c-Myc-deficient crypt cells proliferate slowly 
and are much smaller than WT crypt cells (Muncan et al., 2006).
We previously showed that Mule-mediated regulation of the c-Myc/Miz1 complex prevents 
transcriptional repression of the cell-cycle inhibitors p21 and p15 (Inoue et al., 2013). 
However, Peter et al. proposed that Mule continually targets Miz1 for degradation, 
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derepressing c-Myc target genes that drive the growth of colon cancer cells in vitro and in 
vivo (Peter et al., 2014). When we compared Miz1 and c-Myc protein levels in Mule cKO 
and WT organoids by immunoblotting, there was more c-Myc protein after the loss of Mule 
but there was no difference in Miz1 (Figure S5E). Levels of both c-Myc and Miz1 were 
comparable in cancer stem cells (CSCs) derived from adenomas isolated from APCmin or 
aged Mule cKO mice and cultured as organoids (Figure S5F). Thus, an absence of Mule 
does not stabilize Miz1 in CSCs. P21 was not detectable by immunoblot in either WT or 
Mule cKO organoids, but IHC revealed p21 expression in WT and Mule cKO cells 
differentiating at the crypt-villus interface (Figures S5G and S5H). In addition, IHC revealed 
upregulation of the cell-cycle markers cyclin D, E, and A and the Myc target B23 in Mule 
cKO adenomas (Figures S5I–S5T). Finally, RNAscope in situ hybridization demonstrated 
that ~2-fold more cells coexpress c-Myc and Lgr5 mRNA puncta in Mule cKO APCmin 
adenomas than in APCmin adenomas (Figures S6A, S6B, S6D, S6E, and S6G). Even in 
normal intestine, Mule cKO crypts have ~2-fold more cells that coexpress Lgr5+ and c-Myc+ 
puncta than WT crypts (Figures S6C, S6F, and S6H). Thus, in our system, the loss of Mule 
leads to increased c-Myc at the transcriptional and protein level, which in turn activates c-
Myc target genes and cell-cycle progression in both normal cells and CSCs. The fact that 
CSCs isolated from APCmin adenomas express c-Myc comparable to that seen in CSCs 
isolated from Mule cKO adenomas despite robust Mule expression is a bit puzzling. Thus, 
we acknowledge the possibility that in addition to our findings, other distinct mechanisms of 
c-Myc regulation may be involved.
We next investigated if the ISC expansion seen in aged Mule cKO mice was rescued by c-
Myc deletion. No ISC expansion was observed in 2-year-old Mule c-Myc cDKO mice 
(Figures 4F–4I), but their Paneth cells remained mislocalized (Figures 4J–4M). In APCmin 
mice, Paneth cells are mislocalized because Wnt is hyperactivated, which increases EphB 
and c-Myc expression and disturbs the EphB/ephrinB gradient (Batlle et al., 2002; Sansom 
et al., 2004). Thus, we were surprised that ablation of c-Myc in Mule-deficient mice did not 
restore normal Paneth cell localization. We then surmised that Mule must have additional 
effects on the EphB/ephrinB gradient.
EphB3 Is Overexpressed in Mule cKO Intestinal Crypts
EphB2, EphB3, and their shared ligand ephrinB1 are differentially expressed along the 
crypt-villus axis in a pattern that is tightly regulated by Wnt signaling and dictates cell 
sorting (Batlle et al., 2002; Gregorieff et al., 2005). In Mule cKO intestine, ephrinB1 was 
restricted to differentiated cells while EphB2 was detected in a large proliferative zone, as 
expected (data not shown). However, EphB3, which is normally expressed only at the very 
base of the crypts, was detected higher up in Mule cKO crypts (Figures 5A and 5B). 
Moreover, Mule cKO adenomas showed EphB3 positivity throughout (Figure 5C). Large 
numbers of EphB3-expressing cells were also observed in Mule cKO colon (Figures 5D–
5G). Indeed, the EphB3 expression domain was expanded 2-fold in Mule cKO small 
intestine and colon (Figure 5H). Immunoblotting of Mule cKO organoids to detect EphB/
ephrinB gradient components revealed increased EphB2 and EphB3 expression, and 
ephrinB1 ran at a higher molecular weight suggestive of post-translational modification 
(Figure 5I). Thus, Mule has direct effects on components of the EphB/ephrinB gradient.
Dominguez-Brauer et al. Page 6
Cell Stem Cell. Author manuscript; available in PMC 2016 December 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Mule Promotes Ubiquitin-Mediated Sorting of EphB3 Pools
To investigate if Mule influences EphB3 turnover through Ubn leading to degradation, we 
transiently transfected HEK293T cells with vectors expressing Myc-tagged EphB3 and Flag-
tagged Mule. Immunoprecipitation (IP) analysis revealed a physical interaction between 
Mule and EphB3 (Figure 6A). In the presence of hemagglutinin (HA)-tagged ubiquitin (Ub), 
EphB3 degradation was increased when Mule was overexpressed (Figures 6A and S6I). 
Next, we co-expressed a catalytically inactive Mule mutant (C4341A) with Myc-EphB3 and 
observed only background Ubn levels (presumably due to endogenous Mule or another E3 
ligase) (Figure 6A). When WT Mule was overexpressed, a potential EphB3 cleavage product 
appeared (Figures S6I and S6J), suggesting that some EphB3 is cleaved prior to proteasomal 
degradation. In some cases, the overexpression of Mule increased the EphB3 protein 
suggesting it may stabilize, rather than degrade, a fraction of the EphB3 pool (Figure S6I).
We then co-expressed EphB3, Mule, and WT Ub or Ub in which all lysine residues were 
mutated to arginine except K48 (K480) or Ub in which all lysines were mutated to arginine 
except K63 (K630) in HEK293T cells treated with the proteasome inhibitor MG132. EphB3 
was increased in cells expressing K480, which represented a pool of EphB3 targeted for 
proteasomal degradation (Figure 6A). There was also a pool of K63-Ub EphB3 that was 
presumably recycled. To determine if lysosomal inhibition had the same effect, we 
transfected HEK293T cells with Myc-EphB3, Flag-Mule and HA-Ub, and cultured these 
cells with/without the lysosome inhibitor Bafilomycin A1. EphB3-Ub accumulated in the 
presence of Bafilomycin A1, indicating lysosomal degradation, and Mule overexpression 
further increased this pool (Figure 6B). Similar results were obtained using HT29 human 
colon cancer cells, which lack endogenous EphB3 and express low levels of endogenous 
Mule (Figures S6K and S6L). Thus, Mule mediates both proteasomal and lysosomal EphB3 
degradation.
To investigate how Mule influences EphB3 subcellular localization, we transfected 
HEK293T cells stably expressing His-Mule or empty vector with Myc-EphB3 and 
immunostained them at ~20 hr post-transfection. Although only minimal co-localization of 
Mule and EphB3 occurred at this time point, Mule overexpression induced a redistribution 
of EphB3 from the membrane to various intracellular locations (Figure S7A). To monitor 
EphB3 movement, we created a EphB3 construct with a SNAP-tag that binds membrane-
impermeable SNAP Alexa Fluor 546. We transfected HEK293T cells stably expressing His-
Mule with SNAP-EphB3, with/without ephrinB1. These cells were treated with Bafilomycin 
A1 and stained with anti-EEA1 to mark early endosomes and anti-His to visualize Mule. In 
control cells expressing Myc-EphB3 alone, EphB3 was concentrated normally at the plasma 
membrane (Figure S7A, control panel). In control cells co-expressing SNAP-EphB3 and 
ephrinB1 (but not Mule), SNAP-EphB3 accumulated mainly in the nucleus, with minor 
amounts in early endosomes (Figure 6C, top). However, in cells overexpressing both Mule 
and ephrinB1, SNAP-EphB3 co-localized with Mule in early endosomes (Figure 6C, 
bottom).
To determine if Mule influences EphB3 recycling, HEK293T cells stably expressing His-
Mule were transfected with SNAP-EphB3 and Rab11-dsRed, a marker of sorting 
endosomes. Several such cells showed Mule, EphB3 and Rab11 to be co-localized or in very 
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close proximity (Figure S7B). To confirm that Mule targets EphB3 for lysosomal 
degradation, HEK293T cells expressing His-Mule were transfected with SNAP-EphB3 and 
lamp1-RFP, a lysosomal marker. Co-localization of Mule, EphB3 and Lamp-1 was readily 
detected (Figure S7C). Thus, Mule promotes not only the proteasomal and lysosomal 
degradation of EphB3 but also its cell surface recycling.
Loss of One Allele of EphB3 Rescues the Paneth Cell Mislocalization in Mule cKO Mice
Paneth cell mislocalization can be caused either by Wnt-mediated EphB3 upregulation 
following APC loss (Sansom et al., 2004) or by EphB3 deficiency (Batlle et al., 2002), 
implying that it is perturbation of the EphB/ephrinB gradient that alters Paneth cell 
migration. We hypothesized that the elevated EphB3 in Mule cKO intestine disrupted the 
EphB/ephrinB gradient and thus impaired intestinal cell positioning. Since EphB3 is only 
one component sustaining the EphB/ephrinB gradient, we thought it unlikely that complete 
EphB3 ablation would prevent Paneth cell mislocalization in Mule cKO mice. Instead, 
because EphB3 is haplosufficient (Batlle et al., 2002), we crossed Mule cKO mice with 
EphB3+/− mice (mixed background) and looked for rescue of the Paneth cell defect. 
Intestines from 25 Mule cKO EphB3 mice (females: Mulefl/fl VillinCre EphB3−/− [n = 6] 
and Mulefl/+ VillinCre EphB3+/− [n = 7]; males: Mulefl/y VillinCre EphB3−/− (n = 6) and 
Mulefl/y VillinCre EphB3+/− [n = 6]) were examined. Paneth cells became localized 
normally in the absence of Mule only if one allele of EphB3 was ablated (Figures 7A–7E). 
Thus, the EphB/ephrinB gradient is highly sensitive to alterations in its components and 
regulators, including Mule.
Loss of Mule Favors Colon Cancer-Associated Mutations
Because our Mule cKO organoids became undifferentiated cysts, we investigated if loss of 
Mule alone resulted in activating mutations in the Wnt pathway or inactivating mutations of 
tumor suppressors linked to colon cancer. Whole-exome sequencing was performed on five 
matched adenomas and adjacent normal tissues from two Mule cKO mice (two adenomas in 
mouse 116 and three adenomas in mouse 784), and somatic mutations were identified using 
the MuTect algorithm. The distribution of variant allele frequencies for the numerous 
somatic mutations identified in all samples showed that the most were present at low 
frequencies (Figure 7E), consistent with the heterozygous mutations present in subclonal 
tumor cell populations and also with the presence of normal tissue in tumor samples. There 
were no significant differences in variant allele frequencies in these adenomas (Figure 7F).
To investigate mutations potentially contributing to adenoma development, we identified 
nonsynonymous coding mutations and found that the distribution of variant allele 
frequencies among these mutations was similar to that among total somatic mutations 
(Figure 7F). Nonsynonymous mutations were identified in Trp53, PIK3CA, and EphA2 
(Table S1), which are linked to colon cancer progression. Thus, loss of Mule exerts a 
selective pressure favoring mutations driving gut tumorigenesis. The fact that Mule is 
expressed in the intestinal stem cell niche suggests that these mutations could facilitate the 
transition from stem cells to CSCs. CSCs are believed to drive tumor progression and has 
been linked to disease relapse in colorectal cancer (Zeuner et al., 2014).
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DISCUSSION
The role of Mule in colon cancer has been controversial. In vitro, Mule polyubiquitinates the 
tumor suppressor p53 at K48, targeting it for proteasomal degradation (Chen et al., 2005), 
but Mule also transcriptionally activates the oncogene c-Myc via K63pUb attachment 
(Adhikary et al., 2005). In our in vivo study of intestine-specific Mule cKO mice, we 
observed enhanced intestinal cell proliferation due to elevated c-Myc as well as Paneth cell 
mislocalization due to perturbation of the EphB/ephrinB gradient. Loss of Mule amplifies 
the APCmin phenotype, establishing Mule as a true intestinal tumor suppressor with 
independent effects on Paneth cell regulators.
Constitutive Wnt signaling causes Paneth cells to disperse throughout the intestinal 
epithelium rather than home to the crypt base (Sansom et al., 2004; van Es et al., 2005). Our 
results imply that Mule has another target within the Wnt pathway (besides c-Myc) that can 
amplify β-catenin, resulting in elevated EphB2 and EphB3 in the crypts and a 
disproportionate amount of ephrinB1 in the villi. Notably, several Wnt target genes were 
upregulated in Mule cKO mice. During our studies, it was reported that Mule mediates the 
K63pUbn of Dvl to inhibit Wnt pathway activation (de Groot et al., 2014). We identified 
nuclear β-catenin in Mule cKO adenomas, implying that Mule acts on a substrate upstream 
of β-catenin, but found no difference in Dvl levels in WT and Mule cKO crypts (data not 
shown). Mule’s Ubn of Dvl therefore does not appear to target it for degradation but rather 
modifies its activity. We propose that Mule acts on at least two Wnt pathway components to 
fine-tune Wnt signaling and suppress gut tumorigenesis: (1) Dvl, the cytoplasmic Wnt 
pathway component; and (2) c-Myc, a downstream effector of β-catenin/TCF (Figure 7G).
Disruption of the EphB/ephrinB gradient results in Paneth cell mislocalization (Batlle et al., 
2002). Mule regulates EphB3 pools, and so loss of Mule leads to an EphB3/ephrinB1 
imbalance. Accordingly, Mule cKO mice expressed EphB3 not only in the base of the crypts 
but also higher up, leading to Paneth cell mislocalization. It should be noted that there was 
significant variability in EphB3 expression patterns among our mutants, perhaps reflecting 
the penetrance of Mule deletion. The fact that one EphB3 allele rescues the defect caused by 
the loss of Mule underlines the sensitivity of the EphB/ephrinB1 gradient to alterations in its 
components and regulators.
Our in vitro work has shown that Mule physically interacts with EphB3 and regulates its 
protein levels, as reflected by the altered Paneth cell positioning in Mule cKO intestine and 
organoids. Deregulated Paneth cell localization generates an environment encouraging ISC 
growth (Sato et al., 2011), which might expand nearby clones of mutated ISCs. ISCs and 
early progenitors express EphB3, suggesting that Mule-mediated EphB3 regulation may 
distinguish progenitor cells that differentiate and move up the crypt (i.e., contain K48pUb-
EphB3) from Paneth cells and ISC that inhabit the base of the crypt (ie., contain K63pUb-
EphB3). In vivo, ISCs can still differentiate in the absence of Mule, but we speculate that 
Mule-mediated regulation is needed to safeguard ISCs against unwanted expansion. The 
same may apply to the Paneth cells that sustain ISCs, especially in a highly proliferative 
setting. Significantly, none of our aged Mule c-Myc DKO mice developed adenomas despite 
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partial crypt re-population by c-Myc+ cells, suggesting that Paneth cell mislocalization 
contributes to tumor growth only in a hyperproliferative backdrop.
In human cancers, Mule is subject to somatic mutation, homozygous deletion or 
amplification (http://www.cbioportal.org). In patients with colon and rectal 
adenocarcinomas, some mutations within Mule’s HECT domain have been identified (http://
www.sanger.ac.uk). Our exome-sequencing data revealed that an absence of Mule exerts 
selective pressure on genes linked to colon cancer progression or involved in cell adhesion, 
prote-olysis, or the extracellular matrix. Because EphB3 compartmentalizes incipient tumors 
and inhibits their metastasis (Cortina et al., 2007), loss of Mule function leading to increased 
EphB3 protein may favor the transcriptional silencing of EphB3 that often occurs in 
colorectal cancer. This altered EphB3 expression might permit tumor cells to grow without 
constraints.
In conclusion, our in vitro and in vivo evidence indicate that Mule functions as a tumor 
suppressor in the gut rather than an oncogene. Furthermore, we have shown that Mule 
controls ISC numbers and proliferation via effects on c-Myc and maintains proper levels of 
EphB3 protein by targeting it for proteasomal and lysosomal degradation. Through this 
modulation of EphB3, Mule influences the intestinal cell sorting crucial for avoiding 
colorectal carcinogenesis.
EXPERIMENTAL PROCEDURES
Mice
Mulefl/fl(y) mice were as described previously (Hao et al., 2012) and crossed to Villin-Cre 
(Madison et al., 2002), APCmin(Su et al., 1992), c-Mycfl/fl (de Alboran et al., 2001), or 
EphB3−/− (Orioli et al., 1996) mice. All animal experiments were approved by the 
University Health Network Animal Care Committee (UH-NACC; ID: AUP985).
Histology and IHC
Small intestine and colon from sacrificed mice were placed immediately into 10% neutral 
buffered formalin (NBF). Intestines were opened longitudinally, cleaned, and swiss-rolled. 
Swiss rolls were fixed for ~24 hr in 10% NBF at room temperature (RT). Fixed tissues were 
embedded in paraffin and stained with H&E. Adenomas were graded by inspection of H&E-
stained sections.
For immunohistochemistry (IHC), primary antibodies (Abs) recognized were β-catenin (Cell 
Signaling Technology, #2677), c-Myc (Santa Cruz, #SC764, N-262), lysozyme (#A0099), 
ephrinB1 (R&D Systems, clone AF473), EphB2 (R&D Systems, clone AF467), EphB3 
(R&D Systems, clone AF432), cleaved caspase-3 (Cell Signaling Technology, #9661), Ki67 
(Dako, Tec3 clone), chromogranin A (Immunostar, #20085), p21 (Santa Cruz 
Biotechnology, clone M19), GFP (Novus, 100–1678), cyclin D1 (Cell Signaling Technology, 
#2978), cyclin E1 (Abcam, ab7959), cyclin A1 (Santa Cruz Biotechnology, sc-751), and 
B23 (Sigma, B0556). Anti-LFABP antibody was the kind gift of Dr. Jeffrey Gordon 
(Washington University, St. Louis).
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In Vivo Cell Proliferation
The BrdU In Situ Detection Kit (BD Pharmingen, #550803) was used according to the 
manufacturer’s instructions. Briefly, 4-month-old mice were intraperitoneally injected with 
2.5 mg bromodeoxyuridine (BrdU) and intestines harvested 2 or 24 hr later, followed by 
processing for histology as described above. BrdU+ cells were quantified in 60 crypts per 
mouse (n = 3 mice per group per condition). Migration was determined by measuring the 
distance between the crypt base and the highest labeled cell along the crypt-villus axis in 
five different fields per genotype.
In Situ Hybridization
In situ probes targeting Lgr5, OLMF4, and cryptidin-4 were as described previously (Tian et 
al., 2011; van der Flier et al., 2009; Yilmaz et al., 2012). The Mule probe corresponded to 
expressed sequence tags of a partially sequenced mouse cDNA from Open Biosystems 
(MGI:1926884). To ensure probe specificity, both sense and antisense probes were generated 
by in vitro transcription using DIG RNA labeling mix (Roche) as described previously 
(Gregorieff et al., 2005).
RNAscope In Situ Hybridization
The RNAscope 2-plex Reagent kit (ACD, catalog number [Cat No.] 320700) was used 
according to the manufacturer’s instructions. Huwe1 (Mule)-C1 (Cat No. 434801), c-Myc-
C1 (Cat No. 413451), and Lgr5-C2 (Cat No. 312171) were purchased from ACD. In the 
normal intestine, the number of cells containing the indicated probes was determined in ten 
crypts per mouse (n = 3). In adenomas, the % of cells containing the indicated probes was 
determined in two fields per adenoma (n = 6).
Overexpression Vectors
Human EPHB3 (Myc-DDK-tagged in the pCMV6-Entry vector) was purchased from 
Origene. The human Mule expression vector (pCI.GNeo-3xFlag-12xHis-mouse Mule FL) 
was the kind gift of Dr. Qing Zhong (University of Texas Southwestern Medical Center; 
Zhong et al., 2005). Plasmids pRK5-HA-Ub-WT, pRK5-HA-Ub-K48O, and pRK5-HAUb-
K63O were from Addgene (#17608, 17605, and 17606, respectively). N-terminal SNAP-
tagged EphB3 was generated by PCR-subcloning EphB3 into the SNAP-tag cloning vector 
(New England Biolabs). The human ephrinB1 expression vector was the generous gift of the 
late Dr. Tony Pawson (Mount Sinai Hospital, Toronto).
Cell Culture
HEK293T cells were cultured in DMEM H21 (Invitrogen), and HT29 cells (ATCC) were 
cultured in McCoy 5A Media Modified. Media were supplemented with 10% FBS (Sigma), 
100 U/ml penicillin, and 100 mg/ml streptomycin.
Immunofluorescence
For lysosomal inhibition studies, HEK293T cells (control or stably expressing Mule) were 
grown on poly-D-lysine-coated chamber slides (BD Biosciences) for 16 hr prior to 
transfection with vectors expressing SNAP-EphB3 or ephrinB1. At 6 hr post-transfection, 
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cells were treated with Bafilomycin A1 (10 nM; Sigma) overnight. To visualize EphB3 
localization, transfected cells were labeled with 1 mM SNAP Surface Alexa Fluor 546 (New 
England Biolabs) for 15 min at RT, chased for 15 min at 37°C, and fixed in 4% 
paraformaldehyde. Fixed cells were incubated overnight with rabbit anti-His Ab (Cell 
Signaling Technology, #2365) to identify Mule, and mouse anti-EEA1 Ab (BD Bioscience, 
610457) to identify early endosomes, followed by incubation with secondary Ab rabbit 
Alexa 488 or mouse Alexa Fluor 405, respectively (Invitrogen). Stained cells were mounted 
with Vectashield (Vector Laboratories) and examined using an Olympus FV-1000 confocal 
microscope. Sequential scanning minimized cross-talk between channels and generated a 
profile for each fluorescent signal. Co-localization was identified by direct overlay of 
fluorescence signals from individual channels.
For receptor internalization studies, control or Mule-overexpressing HEK293T cells were 
transfected with Myc-EphB3 vector. At 20 hr post-transfection, cells were fixed in ice cold 
100% methanol for 15 min. Cells were incubated overnight with anti-His antibody (Mule), 
then for 1 hr at RT with anti-Myc-tag (Cell Signaling Technology, 9B11), and 1 hr with 
rabbit anti-Cy2 and mouse anti-Cy3 Abs (Vector Laboratories). Endosomal and lysosomal 
sorting experiments were conducted as above using Rab11-dsRed and Lamp1-RFP 
(Addgene).
Ubiquitination
HEK293T or HT29 cells were transfected with Myc-EphB3 and Flag-Mule, plus either HA-
Ub, HA-Ub-K48O, or HA-Ub-K63O, using Lipofectamine 2000 (Invitrogen) as described 
previously (Inoue et al., 2013). Proteasomal degradation was determined by adding MG132 
(20 mM; Sigma) at 24 hr post-transfection and culturing cells for 3 hr. Lysosomal 
degradation was determined by adding Bafilomycin A1 (10 nM; Sigma) at 6 hr post-
transfection and culturing cells overnight. Lysates were prepared as described previously 
(Inoue et al., 2013). Supernatants were immunoprecipitated with anti-Myc-tag (Cell 
Signaling Technology, 9B11) for 2 hr at 4°C (overnight at 4°C for HT29 cells). Protein G-
Sepharose beads were added with rocking for 1–2 hr at 4°C. Immunocomplexes were 
washed four times with lysis buffer and subjected to immunoblotting.
Immunoblotting
Standard immunoblotting was performed using Abs recognizing HA (Santa Cruz 
Biotechnology, clone Y-11), Flag (Sigma clone M2), Myc-tag (Cell Signaling Technology, 
9B11), vinculin (Abcam, SPM227), Mule (Bethyl Laboratories, A300-486A), ephrinB1 
(R&D Systems, clone AF473), EphB2 (R&D clone AF467), EphB3 (R&D Systems, clone 
AF432), Miz1 (Santa Cruz Biotechnology, sc-22837), c-Myc (Santa Cruz Biotechnology, 
N262), α-tubulin (Sigma), and β-actin (Sigma). Anti-mouse and anti-rabbit HRP-conjugated 
secondary Abs were from Thermo Fisher Scientific. Quantification of immunoblots was 
performed using Image J software (NIH).
RT-PCR
RNA was extracted using the NucleoSpin RNA II kit (Macherey-Nagel) and reverse 
transcribed using the iScript cDNA synthesis kit (Bio-Rad). qRT-PCR was performed using 
Dominguez-Brauer et al. Page 12
Cell Stem Cell. Author manuscript; available in PMC 2016 December 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
these cDNAs as templates and Power SYBR Green PCR Master Mix (Applied Biosystems) 
on an ABI 7700 instrument (Applied Biosystems). All procedures were performed according 
to the manufacturer’s instructions. Each sample was assayed in triplicate and data were 
analyzed using SDS software (Applied Biosystems). Primer sequences are available upon 
request.
Organoids
Standard organoids were generated from intestines of Mule cKO and WT litter-mate mice 
(2–4 months old) as described previously (Sato et al., 2009). WT and Mule cKO organoids 
were passaged once a week. Crypt culture medium (Sato et al., 2009) was changed every 
other day.
CSC organoids were generated by incubating resected adenomas in DMEM plus 10% FBS 
containing Dispase (12.5 mg/50 ml medium; Life Technologies) and Collagenase from 
Clostridium histolyticum (12.5 mg/50 ml medium; Sigma) for 30 min to 1 hr (depending on 
adenoma number) at 37°C on a nutator with vortexing every 15 min. Digested tissues were 
passed through a 40-µm strainer and mashed with a plunger. Cells were collected by 
centrifugation at 1,000 rpm for 5 min and pellets were resuspended in 1–2 ml DMEM plus 
Y-27632 dihydrochloride monohydrate (10 µM, Sigma). A total of 5,000 cells/25 µl of 
Matrigel (BD Biosciences) in crypt culture medium were cultured in a 48-well dish, with 
Y-27632 dihydrochloride monohydrate added for the first week.
Quantitation of EphB3 Domains and c-Myc+ Cells
The EphB3 domain in 100 crypts per genotype (six fields per mouse; n = 3 per group) was 
determined using the Photoshop ruler tool (Adobe) to measure the distance between the 
lowest and highest EphB3+ cells in the crypt. A 250-mm scale bar was measured as 278 
pixels and used as the reference. In normal tissue, c-Myc+ cells were counted in 60 crypts 
per mouse (n = 3 mice/group/condition). In adenomas, c-Myc+ cells were counted in four 
fields per adenoma (n = 6 mice). The mean number of c-Myc+cells/mouse was used to 
determine the total mean for the group.
Whole-Exome Sequencing
Whole-exome sequencing and data analysis were performed at the Princess Margaret 
Genomics Centre. DNA was extracted from freshly excised adenomas and adjacent normal 
gut using NucleoSpin Tissue XS (Macherey-Nagel). Read quality was checked using 
FASTQC (v. 0.11.2), and raw sequence data were aligned to the mouse genome (mm9) using 
BWA-MEM (v. 0.7.10). Alignment quality was assessed using Qualimap (v. 2.0). Bam files 
were pre-processed using Picard (v. 1.124) to mark duplicates and GATK (v. 3.2-2) to 
perform local realignment around indels and to perform base quality score recalibration. 
MuTect (v. 1.1.5) was used to identify somatic point mutations in tumor samples relative to 
paired normal tissue. Mutations were annotated using ANNOVAR (v. 2014-11–12).
Statistics
p values for intergroup comparisons and mouse survival were determined using the unpaired 
Student’s t test and the Mantel-Cox test, respectively. p < 0.05 is considered significant.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Mule regulates murine intestinal stem and progenitor cell proliferation
• Mule modulates the Wnt pathway via c-Myc
• Mule targets EphB3 to the proteasome and lysosome
• Proper protein levels of EphB3 are required to maintain the EphB/
ephrinB gradient
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In Brief
Dominguez-Brauer et al. show that the ubiquitin ligase Mule fine-tunes the Wnt pathway 
via c-Myc to control unwarranted proliferation and stem cell expansion. Mule also 
regulates the levels of EphB3 to maintain the EphB/ephrinB gradient, which is 
responsible for cell positioning along the crypt-villus axis.
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Figure 1. Loss of Mule Exacerbates the APCmin Phenotype
(A) Kaplan-Meier analysis of tumor-free survival of APCmin, Villin-Cre APCmin, and Mule 
cKO APCmin mice.
(B and C) Total adenoma numbers in small intestine (B) and colon (C) of the indicated 
strains. Data are mean ± SEM (n = 5).
(D and E) Representative H&E-stained sections of the small intestines in (B); scale bar, 1 
mm.
See also Figures S1A–S1D.
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Figure 2. Mule Deficiency in the APCmin Background Hyperactivates the Wnt/β-Catenin 
Pathwayand Generates Adenomas Populated by ISC and Paneth Cells
Adenomas from APCmin (A, B, E, F, I, J, M, and N) and Mule cKO APCmin (C, D, G, H, K, 
L, O, and P) littermates were immunostained to detect β-catenin (A–D,), c-Myc (E–H), Lgr5 
(I–L; ISC marker), and cryptidin (M,N,O,P; Paneth cell marker). (A, C, E, G, I, K, M, and 
O)Low-magnification images; scale bar, 100µm. (B, D, F, H, J, L, N, and P) High-
magnification images of the boxed areas within the adenomas in the low-magnification 
images; scale bar, 100 µm. Data are representative of five mice per group. Adenomas are 
circled in red and marked with red “A.” Normal tissue is marked with red “N.” See also 
Figures S1E–S1X.
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Figure 3. Loss of Mule Alone Promotes Tumorigenesis
(A–D) Sections of small intestines of the indicated mouse strains (age 4 months, n = 3/
group) stained to detect lysozyme. (A and B) Low-magnification images; scale bars, 100 
µm. (C and D) High-magnification images of the boxed areas in (A) and (B); scale bars, 100 
µm.
(E–P) Sections of normal WT intestine (E, H, K, and N) and spontaneous Mule cKO 
adenomas (F, G, I, J, L, M, O, and P) from 1- to 2-year-old mice (n = 30/group) stained to 
detect β-catenin (E–G), c-Myc (H–J), LGR5 (K–M), or cryptidin-4 (N–P). (E, H, K, and N) 
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WT intestine; scale bar, 100 µm. (F, I, L, and O). Low-magnification images of Mule cKO 
adenomas; scale bar, 100 µm. (G, J, M, and P) High-magnification images of the boxed areas 
within the Mule cKO adenomas shown in (F, I, L, and O); scale bars, 100 µm. Adenomas are 
circled in red and marked with red “A.” Normal tissue is marked with red “N.” See also 
Figures S2–S4.
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Figure 4. Loss of c-Myc in Mule cKO Mice Restores Intestinal Cell Proliferation but Does Not 
Rescue Paneth Cell Mispositioning
(A–D) BrdU staining of intestines from the indicated mouse strains (age 4 months, n = 3/
group). Scale bar, 100 µm.
(E) Quantitation of BrdU+ cells/crypt in the mice in (A)-(D). Data are the mean ± SEM (n = 
3).
(F–M) Staining to detect Olmf4 (F–I) and cryptidin-4 (J–M) in intestines of the indicated 
strains (age ~2 years, n = 10/group). Scale bar, 100 µm.
See also Figures S5 and S6A–S6H.
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Figure 5. Mule Regulates EphB3 Protein Levels
(A–C) Staining to detect EphB3 protein in small intestines of WT (A) and Mule cKO (B) 
mice, and in a Mule cKO adenoma (C). Black arrows, EphB3 positivity. Scale bars represent 
25 µm (A and B) and 100 µm (C).
(D–G) Staining to detect EphB3 in colons of WT (D and E) and Mule cKO (F and G) mice 
(n = 5/group). (D and F) Low-magnification images; scale bar, 100 µm.
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(G and H) High-magnification images of the boxed areas in the low-magnification images; 
scale bar, 25 µm. (H) Quantitation of EphB3 domains in small intestine and colon of the 
indicated mice (n = 3/ group). Data are mean ± SEM.
(I) Immunoblot to detect the indicated proteins in lysates of organoids generated from the 
indicated mouse strains (n = 3 mice/group). β-Actin, loading control.
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Figure 6. Mule Promotes Proteasomal and Lysosomal Degradation of EphB3 as well as Its 
Ubiquitin-Mediated Internalization
(A) IP analysis of HEK293T cells transfected with constructs expressing Flag-Mule or 
catalytically inactive Flag-Mule (C4341A; mutant, Mt), plus Myc-EphB3, and/ or WT HA-
Ub, HA-Ub in which all lysine residues were mutated except K48 (K48O), or HA-Ub in 
which all lysines were mutated except K63 (K63O), as indicated. Cells were treated with 
MG132. EphB3 was immunoprecipitated with anti-Myc Ab and the blot probed with anti-
Flag and anti-HA Abs. α-Tubulin, loading control.
(B) IP analysis as in(A) ofHEK293T cells that were transfected with constructs expressing 
Flag-Mule, Myc-EphB3 and/or WTHA-Ub, and treated with Bafilomycin A1, as indicated.
(C) Sequential scanning immunofluorescence co-localization analysis of control HEK293T 
cells and HEK293T cells overexpressing His-Mule that were transfected with SNAP-EphB3 
plus ephrinB1, treated with Bafilomycin A1, and stained to detect all three proteins. Scale 
bar, 10 µm.
See also Figures S6I–S6L and S7.
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Figure 7. EphB3 Restores Normal Localization of Mule cKO Paneth Cells, and Loss of Mule 
Favors Colon Cancer-Associated Mutations
(A–D) Staining to detect lysozyme (Paneth cell marker) in small intestine of the indicated 
strains (n = 5–6 mice per group). Scale bar, 100 µm.
(E and F) Somatic mutations in Mule cKO adenomas. (E) Number of total somatic 
mutations, including synonymous and intronic variants (blue) and nonsynonymous coding 
variants (red) in five adenomas from two Mule cKO mice (116 and 784).
(F) Allele frequency distributions of mutant alleles observed for all somatic mutations (blue) 
and nonsynonymous coding mutations (red) for the five adenomas in (E).
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(G) Model of proposed mechanism of Mule-mediated regulation of Wnt and EphB3. In the 
absence of Wnt signaling (left), β-catenin is recruited into the APC/Axin/GSK3b/CK1 
destruction complex, which degrades β-catenin and prevents its translocation into the 
nucleus. The transcription of β-catenin target genes such as c-Myc and EphB3 is therefore 
blocked. When the Wnt pathway is active (right), Wnt binds to its receptor Frizzled and co-
receptor LRP5/6 to activate Disheveled (Dvl), blocking APC/Axin/ GSK3b/CK1-mediated 
β-catenin degradation. Stabilized β-catenin translocates into the nucleus and together with 
TCF/LEF activates target gene transcription. Mule fine-tunes this pathway by inhibiting Dvl 
multimerization and thus the activation of the Wnt pathway and by controlling the 
production of the EphB3 and c-Myc proteins needed to regulate intestinal cell proliferation 
and positioning; these activities collectively contribute to tumor suppression. When the 
APC/Axin/ GSK3b/CK1 destruction complex cannot function, as occurs following APC 
mutation, Mule regulates c-Myc and targets EphB3 for proteasomal and/or lysosomal 
degradation in an attempt to restrain proliferation and maintain a proper EphB/ephrinB 
gradient.
See also Table S1.
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